Palmitoyl Tetrapeptide-10 Supplier

Palmitoyl Tetrapeptide-10: Smoothing Lipopeptide for Type IV Collagen at the DEJ

Palmitoyl Tetrapeptide-10 (CAS 887140-79-6, MW ~620 g/mol) is a smoothing lipopeptide that stimulates type IV collagen production specifically at the dermal-epidermal junction (DEJ). The DEJ is the specialized basement membrane zone where the epidermis anchors to the dermis through a network of type IV collagen, laminins, and anchoring fibrils. Deterioration of this junction with age directly causes the flattening of rete ridges, reduced nutrient exchange, and the visible surface texture changes that characterize mature skin.

Mechanism: Type IV Collagen and DEJ Integrity

Unlike the fibrillar collagens (types I and III) that provide bulk dermal tensile strength, type IV collagen forms sheet-like networks exclusively within basement membranes. At the DEJ, type IV collagen creates the structural platform for laminin-332 binding and hemidesmosone anchoring–the mechanical connections that hold the epidermis firmly attached to the dermis. Age-related type IV collagen loss causes DEJ flattening, which reduces the interdigitated surface area between skin layers by up to 35% between ages 30 and 80. Palmitoyl Tetrapeptide-10 upregulates type IV collagen gene expression in basal keratinocytes and dermal fibroblasts adjacent to the DEJ.

Efficacy Evidence

In a 56-day controlled study, subjects applying Palmitoyl Tetrapeptide-10 at 100 ppm showed a 19% improvement in skin smoothness parameters measured by optical profilometry (surface roughness Ra values). This improvement reflects restored DEJ undulation patterns that create a more uniform light reflection surface. The 56-day timeline aligns with approximately two full epidermal turnover cycles, confirming that the smoothing effect originates from structural remodeling at the DEJ rather than superficial hydration or temporary optical effects.

Formulation Specifications

The palmitoyl (C16) conjugation makes this peptide oil-soluble. Recommended concentration range is 50-200 ppm in finished cosmetic formulations. Incorporate into emulsion oil phases at processing temperatures below 45 degrees Celsius. Maintain final product pH between 5.0 and 7.0 for optimal peptide stability. Compatible with standard cosmetic oil-phase ingredients including dimethicone, squalane, jojoba oil, and common emulsifier systems. The MW ~620 g/mol is within the range that benefits from enhanced delivery via lipid nanoparticle encapsulation or lamellar phase structuring.

Application Categories

  • Skin smoothing and texture-refining serums for visible pore and roughness reduction
  • Anti-aging moisturizers targeting the structural causes of dull, uneven-textured skin
  • DEJ-focused formulations paired with retinoids for full basement membrane renewal
  • Hand and body treatments for crepey, thin skin on extremities
  • Professional treatment products for post-peel recovery and structural rebuilding

Synergistic Formulation Strategy

The most effective approach combines Palmitoyl Tetrapeptide-10 (targeting type IV collagen at the DEJ) with fibrillar collagen stimulators such as Palmitoyl Tripeptide-1 (targeting types I and III in the bulk dermis). This multi-layer collagen strategy addresses both the structural foundation and the deep tissue simultaneously. Adding retinol or retinal further supports DEJ renewal by increasing epidermal turnover rate and stimulating laminin production. For formulations focused on surface smoothness, combining with gentle AHAs (mandelic or lactic acid at 2-5%) provides complementary exfoliation benefits alongside the biological smoothing mechanism.

Quality Assurance and Ordering

TCS NEXUS S.L. produces Palmitoyl Tetrapeptide-10 from our warehouse in Valencia, Spain under COSMOS-validated. Evaluation orders begin at 1 g MOQ with production orders at 100 g MOQ. EU delivery is 5-7 business days standard. Full Certificate of Analysis accompanies every lot with HPLC purity data, mass spectrometry identity confirmation, amino acid analysis, and complete microbiological panel results.

Frequently Asked Questions

What makes type IV collagen different from type I collagen?

Type I collagen forms rope-like fibrils providing tensile strength in the bulk dermis. Type IV collagen forms sheet-like networks in basement membranes, specifically at the dermal-epidermal junction. Both decline with age, but they serve fundamentally different structural roles and require different peptide signals to stimulate.

How does DEJ restoration improve visible skin texture?

A healthy DEJ has an undulating, interdigitated structure that keeps the epidermis firmly anchored and well-nourished. As type IV collagen degrades, this junction flattens, causing surface irregularities. Restoring DEJ structure re-establishes uniform surface topography, which is what the 19% smoothness improvement reflects.

Can Palmitoyl Tetrapeptide-10 be combined with retinol?

Yes. Retinol stimulates epidermal turnover and laminin production, complementing the type IV collagen stimulation from this peptide. Both ingredients target DEJ health through different pathways, making them an effective pairing for mature skin formulations.

Technical Profile

Palmitoyl Tetrapeptide-10 modulates inflammatory responses and supports dermal matrix quality, making it a versatile lipopeptide for advanced anti-aging formulations focused on skin resilience, tone improvement, and overall skin-quality enhancement.

Best-Fit Applications

  • Premium skin-quality and texture-support products
  • Advanced anti-aging lipopeptide formulations
  • Product lines built around multi-peptide palmitoyl systems

Related Peptide Portfolio: TCS NEXUS supplies a connected range of anti-aging, brightening, repair, and matrix-support peptides for cosmetic formulators across Europe.

Technical Support and Samples

Request COA documents, sample availability, or support for custom synthesis.

Request Custom Synthesis
Contact Technical Team

Scroll to Top